Opocrin S.p.A. acquires a majority stake in Omikron Italia s.r.l.
Omikron Italia is a Pharmaceutical Company intending to be a partner for Specialists and General Practitioners able to answer in an exhaustive and gradual way to the therapeutic needs of Vascular patients and of those affected by main eye diseases.
Previous PostOpocrin S.p.A. festeggia i 60 anni di attività
Next PostOpocrin S.p.A. acquires 100% of Laboratori Derivati Organici (LDO) shares and the Opocrin Group is born
